Literature DB >> 19546478

Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation.

Manfred Kneilling1, Reinhard Mailhammer, Lothar Hültner, Tanja Schönberger, Kerstin Fuchs, Martin Schaller, Daniel Bukala, Steffen Massberg, Christian A Sander, Heidi Braumüller, Martin Eichner, Konrad L Maier, Rupert Hallmann, Bernd J Pichler, Roland Haubner, Meinrad Gawaz, Klaus Pfeffer, Tilo Biedermann, Martin Röcken.   

Abstract

Signaling through tumor necrosis factor receptor 1 (TNFR1) controls bacterial infections and the induction of inflammatory Th1 cell-mediated autoimmune diseases. By dissecting Th1 cell-mediated delayed-type hypersensitivity responses (DTHRs) into single steps, we localized a central defect to the missing TNFR1 expression by endothelial cells (ECs). Adoptive transfer and mast cell knockin experiments into Kit(W)/Kit(W-v), TNF(-/-), and TNFR1(-/-) mice showed that the signaling defect exclusively affects mast cell-EC interactions but not T cells or antigen-presenting cells. As a consequence, TNFR1(-/-) mice had strongly reduced mRNA and protein expression of P-selectin, E-selectin, ICAM-1, and VCAM-1 during DTHR elicitation. In consequence, intravital fluorescence microscopy revealed up to 80% reduction of leukocyte rolling and firm adhesion in TNFR1(-/-) mice. As substitution of TNF(-/-) mice with TNF-producing mast cells fully restored DTHR in these mice, signaling of mast cell-derived TNF through TNFR1-expressing ECs is essential for the recruitment of leukocytes into sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546478      PMCID: PMC2731644          DOI: 10.1182/blood-2008-11-187682

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  79 in total

Review 1.  Medical treatment of inflammatory bowel diseases.

Authors:  Gert Van Assche; Séverine Vermeire; Paul Rutgeerts
Journal:  Curr Opin Gastroenterol       Date:  2005-07       Impact factor: 3.287

2.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

3.  Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B.

Authors:  Michele A Grimbaldeston; Susumu Nakae; Janet Kalesnikoff; Mindy Tsai; Stephen J Galli
Journal:  Nat Immunol       Date:  2007-09-02       Impact factor: 25.606

Review 4.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.

Authors:  Thomas Hehlgans; Klaus Pfeffer
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

Review 5.  New therapies for rheumatoid arthritis.

Authors:  F Goldblatt; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

6.  Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice.

Authors:  Yusheng Wang; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 7.  Design of effective immunotherapy for human autoimmunity.

Authors:  Marc Feldmann; Lawrence Steinman
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

Review 8.  TNF pathophysiology in murine models of chronic inflammation and autoimmunity.

Authors:  George Kollias
Journal:  Semin Arthritis Rheum       Date:  2005-04       Impact factor: 5.532

9.  Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.

Authors:  Kristian Reich; Frank O Nestle; Kim Papp; Jean-Paul Ortonne; Robert Evans; Cynthia Guzzo; Shu Li; Lisa T Dooley; Christopher E M Griffiths
Journal:  Lancet       Date:  2005 Oct 15-21       Impact factor: 79.321

10.  Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1.

Authors:  Alexander Zarbock; Clifford A Lowell; Klaus Ley
Journal:  Immunity       Date:  2007-05-31       Impact factor: 31.745

View more
  18 in total

1.  Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessels.

Authors:  David J Rowlands; Mohammad Naimul Islam; Shonit R Das; Alice Huertas; Sadiqa K Quadri; Keisuke Horiuchi; Nilufar Inamdar; Memet T Emin; Jens Lindert; Vadim S Ten; Sunita Bhattacharya; Jahar Bhattacharya
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

2.  ANTI-INFECTIVE PROTECTIVE PROPERTIES OF S100 CALGRANULINS.

Authors:  Kenneth Hsu; Chantrakorn Champaiboon; Brian D Guenther; Brent S Sorenson; Ali Khammanivong; Karen F Ross; Carolyn L Geczy; Mark C Herzberg
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-12-04

3.  The tumor microenvironment in colorectal carcinogenesis.

Authors:  Vijay G Peddareddigari; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Microenviron       Date:  2010-03-05

4.  Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-α.

Authors:  Ok Hee Chai; Eui-Hyeog Han; Hern-Ku Lee; Chang Ho Song
Journal:  Exp Mol Med       Date:  2011-01-31       Impact factor: 8.718

5.  T-helper-1-cell cytokines drive cancer into senescence.

Authors:  Heidi Braumüller; Thomas Wieder; Ellen Brenner; Sonja Aßmann; Matthias Hahn; Mohammed Alkhaled; Karin Schilbach; Frank Essmann; Manfred Kneilling; Christoph Griessinger; Felicia Ranta; Susanne Ullrich; Ralph Mocikat; Kilian Braungart; Tarun Mehra; Birgit Fehrenbacher; Julia Berdel; Heike Niessner; Friedegund Meier; Maries van den Broek; Hans-Ulrich Häring; Rupert Handgretinger; Leticia Quintanilla-Martinez; Falko Fend; Marina Pesic; Jürgen Bauer; Lars Zender; Martin Schaller; Klaus Schulze-Osthoff; Martin Röcken
Journal:  Nature       Date:  2013-02-03       Impact factor: 49.962

Review 6.  Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?

Authors:  Martin Voss; Johanna Kotrba; Evelyn Gaffal; Konstantinos Katsoulis-Dimitriou; Anne Dudeck
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

7.  Differential regulation of human and murine P-selectin expression and function in vivo.

Authors:  Zhenghui Liu; Jonathan J Miner; Tadayuki Yago; Longbiao Yao; Florea Lupu; Lijun Xia; Rodger P McEver
Journal:  J Exp Med       Date:  2010-12-13       Impact factor: 14.307

8.  Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils.

Authors:  Jie Zhang; Pilar Alcaide; Li Liu; Jiusong Sun; Aina He; Francis W Luscinskas; Guo-Ping Shi
Journal:  PLoS One       Date:  2011-01-14       Impact factor: 3.240

9.  Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells.

Authors:  Kamran Ghoreschi; Jürgen Brück; Christina Kellerer; Caishu Deng; Haiyan Peng; Oliver Rothfuss; Rehana Z Hussain; Anne R Gocke; Annedore Respa; Ivana Glocova; Nadejda Valtcheva; Eva Alexander; Susanne Feil; Robert Feil; Klaus Schulze-Osthoff; Rudolf A Rupec; Amy E Lovett-Racke; Ralf Dringen; Michael K Racke; Martin Röcken
Journal:  J Exp Med       Date:  2011-10-10       Impact factor: 14.307

10.  Tetraspanins in mast cells.

Authors:  Martin Köberle; Susanne Kaesler; Wolfgang Kempf; Florian Wölbing; Tilo Biedermann
Journal:  Front Immunol       Date:  2012-05-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.